AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cleo Diagnostics Ltd

0.465

-0.015-3.12%

Volume:154.89K

Turnover:73.34K

Market Cap:63.64M

PE:-15.50

High:0.490

Open:0.480

Low:0.465

Close:0.480

52wk High:0.900

52wk Low:0.310

Shares:136.86M

Float Shares:73.01M

Volume Ratio:0.71

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.030

EPS(LYR):-0.031

ROE:-49.57%

ROA:-27.12%

PB:7.21

PE(LYR):-14.94

Loading ...

Overview Company News Filings

Cleo Diagnostics Selects Bio-Techne's Platform as Immunoassay Instrument for Ovarian Cancer Blood Test; Shares Jump 3%

MT Newswires Live

ASX Penny Stocks Under A$500M Market Cap: 3 Promising Picks

Simply Wall St.

Cleo Diagnostics to Complete US Trial, Advance US FDA Submission in 2026; Shares Down 3%

MT Newswires Live

Cleo Diagnostics Ltd-Chairman's End of Year Letter to Shareholders

THOMSON REUTERS

Cleo Diagnostics Raises AU$5 Million via Placement; Shares Fall 6%

MT Newswires Live

Cleo Diagnostics Raises A$5M

Cleo Diagnostics Ltd - Raises a$5M at a$0.60 per Share

THOMSON REUTERS

BRIEF-Cleo Diagnostics Seeks Trading Halt Pending Material Capital Raising Announcement

ASX Penny Stock Highlights Featuring Atturra And Two Others

Simply Wall St.

Cleo Diagnostics Ltd-Cleo Appoints First Key Opinion Leader to Support US Market

THOMSON REUTERS

3 Promising ASX Penny Stocks With Market Caps Below A$3B

Simply Wall St.

Cleo Diagnostics Receives Positive US FDA Feedback for Ovarian Cancer Test; Shares Up 9%

MT Newswires Live

Companies Like Cleo Diagnostics (ASX:COV) Are In A Position To Invest In Growth

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COV.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"COV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COV.AU\",,,,,undefined,":{"symbol":"COV.AU","market":"AU","secType":"STK","nameCN":"Cleo Diagnostics Ltd","latestPrice":0.465,"timestamp":1774242720000,"preClose":0.48,"halted":0,"volume":154894,"delay":0,"changeRate":-0.031249999999999913,"nameEN":"Cleo Diagnostics Ltd","floatShares":73005001,"shares":136862085,"eps":-0.03,"marketStatus":"Not Yet Opened","change":-0.015,"latestTime":"03-23 16:12:00 AEDT","open":0.48,"high":0.49,"low":0.465,"amount":73343,"amplitude":0.052083,"askPrice":0.475,"askSize":10000,"bidPrice":0.465,"bidSize":22513,"shortable":3,"etf":0,"ttmEps":-0.03,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774306800000},"marketStatusCode":0,"adr":0,"listingDate":1692540000000,"exchange":"ASX","adjPreClose":0.48,"openAndCloseTimeList":[[1774220400000,1774242000000]],"volumeRatio":0.7069763794325218,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"COV.AU","preClose":0.48,"auctionPrice":0.48,"auctionVolume":1110,"auction":3,"marketStatus":"盘后竞价","timestamp":1774242021321}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COV.AU\",,,,,undefined,":{"symbol":"COV.AU","floatShares":73005001,"roa":"-27.12%","roe":"-49.57%","lyrEps":-0.031121,"volumeRatio":0.7069763794325218,"shares":136862085,"dividePrice":0,"high":0.49,"amplitude":0.052083,"preClose":0.48,"low":0.465,"week52Low":0.31,"pbRate":"7.21","psRate":"24.84","week52High":0.9,"institutionHeld":0,"latestPrice":0.465,"committee":0.384861,"eps":-0.03,"divideRate":0,"volume":154894,"delay":0,"ttmEps":-0.03,"open":0.48,"prevYearClose":0.605,"prevWeekClose":0.48,"prevMonthClose":0.585,"prevQuarterClose":0.605,"fiveDayClose":0.47,"twentyDayClose":0.545,"sixtyDayClose":0.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COV.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COV.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612492145","title":"Cleo Diagnostics Selects Bio-Techne's Platform as Immunoassay Instrument for Ovarian Cancer Blood Test; Shares Jump 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612492145","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612492145?lang=en_us&edition=fundamental","pubTime":"2026-02-18 10:12","pubTimestamp":1771380745,"startTime":"0","endTime":"0","summary":"Cleo Diagnostics  selected Bio-Techne's Ella enzyme-linked immunosorbent assay platform as the immunoassay instrument for its ovarian cancer blood test, according to a Wednesday Australian bourse filing.The companies are progressing discussions to enter into a binding agreement to start analytical validation of Cleo's test kits, the filing said. Cleo has been using the Ella platform in-house since September 2025 and confirmed the platform's capability to deliver its tests.The finished kits will then be used test the around 500 blood samples collected as part of Cleo's pivotal clinical trial, per the filing.Cleo Diagnostics' shares jumped nearly 3% in recent trading on Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0034390439.USD","BK7067","BK4121","BK4585","BK4588","COV.AU","TECH","IE00B19Z6F94.USD","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2603957290","title":"ASX Penny Stocks Under A$500M Market Cap: 3 Promising Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2603957290","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603957290?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:08","pubTimestamp":1768529332,"startTime":"0","endTime":"0","summary":"The Australian market today presents a mixed outlook, with the Aussie dollar inching closer to 67 cents against the USD and equities poised for a flat opening. For investors interested in exploring beyond well-known names, penny stocks—typically smaller or newer companies—offer intriguing possibilities. Despite the term's outdated feel, these stocks can still provide surprising value when backed by solid financials, offering potential for significant returns and stability.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3051000-choice1-main-header/1585186568557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3051000-choice1-main-header/1585186568557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-sks/sks-technologies-group-shares/news/asx-penny-stocks-under-a500m-market-cap-3-promising-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-sks/sks-technologies-group-shares/news/asx-penny-stocks-under-a500m-market-cap-3-promising-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7045","BK7061","KSC.AU","BK7143","SSM.AU","MTO.AU","BK7503","BK7128","BK7055","BK7058","BK7132","BK7050","SKS.AU","MXI.AU","COV.AU","BK7016","BK7067","BK7104","IGL.AU","DSK.AU","VRS.AU","EDU.AU","PPL.AU","WAF.AU","BK7023","BK7077","BK7506","PPS.AU"],"gpt_icon":0},{"id":"2595620550","title":"Cleo Diagnostics to Complete US Trial, Advance US FDA Submission in 2026; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595620550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595620550?lang=en_us&edition=fundamental","pubTime":"2025-12-29 11:14","pubTimestamp":1766978067,"startTime":"0","endTime":"0","summary":"Cleo Diagnostics  said the company is set to complete its US clinical trial, advance to Food and Drug Administration  510 submission, and start commercial manufacturing of its ovarian cancer detection product in 2026, according to a Monday filing with the Australian bourse.The company said it will also focus on the development of its mass screening program.Shares fell past 3% in afternoon trade Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","COV.AU"],"gpt_icon":0},{"id":"2595272140","title":"Cleo Diagnostics Ltd-Chairman's End of Year Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2595272140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595272140?lang=en_us&edition=fundamental","pubTime":"2025-12-29 08:23","pubTimestamp":1766967834,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUE6LQQPX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COV.AU","BK7067"],"gpt_icon":0},{"id":"2592282769","title":"Cleo Diagnostics Raises AU$5 Million via Placement; Shares Fall 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592282769","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592282769?lang=en_us&edition=fundamental","pubTime":"2025-12-18 10:12","pubTimestamp":1766023946,"startTime":"0","endTime":"0","summary":"Cleo Diagnostics  raised AU$5 million via a placement of 8.3 million shares at AU$0.60 per share, to institutional investors and existing unrelated shareholders, according to a Thursday filing with the Australian bourse.The offer price is an 8.4% discount to the company's 15-day volume weighted average price, the filing said.The company will also issue 833,333 new options, at AU$0.90 each, expiring three years from the date of issue, the filing added.The funds will be used to launch the company's ovarian cancer test in the US, provide working capital, and for general corporate purposes, the company said.The placement is expected to settle on Dec. 24, the company said.Shares of the company fell 6% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","COV.AU"],"gpt_icon":0},{"id":"2592283928","title":"Cleo Diagnostics Raises A$5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2592283928","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592283928?lang=en_us&edition=fundamental","pubTime":"2025-12-18 10:09","pubTimestamp":1766023780,"startTime":"0","endTime":"0","summary":"Dec 18 (Reuters) - Cleo Diagnostics Ltd ::*RAISES A$5M AT A$0.60 PER SHARE*Further company coverage: COV.AX* ((Reuters.Briefs@thomsonreuters.com;))  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 17-DEC-202521:44:24.157 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nRSD77myH7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COV.AU","BK7067"],"gpt_icon":0},{"id":"2592622949","title":"Cleo Diagnostics Ltd -  Raises a$5M at a$0.60 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2592622949","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592622949?lang=en_us&edition=fundamental","pubTime":"2025-12-18 06:54","pubTimestamp":1766012070,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XN1EU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COV.AU","BK7067"],"gpt_icon":0},{"id":"2592930748","title":"BRIEF-Cleo Diagnostics Seeks Trading Halt Pending Material Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592930748","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592930748?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:51","pubTimestamp":1765921879,"startTime":"0","endTime":"0","summary":"BRIEF-Cleo Diagnostics Seeks Trading Halt Pending Material Capital Raising AnnouncementDec 17 (Reuters) - Cleo Diagnostics Ltd COV.AX:SEEKS TRADING HALT PENDING MATERIAL CAPITAL RAISE ANNOUNCEMENTFurther company coverage: COV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XM0XO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COV.AU","BK7067"],"gpt_icon":0},{"id":"2585438808","title":"ASX Penny Stock Highlights Featuring Atturra And Two Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2585438808","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585438808?lang=en_us&edition=fundamental","pubTime":"2025-11-24 03:01","pubTimestamp":1763924508,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a challenging period, with futures indicating a significant downturn and volatility on the rise. Despite these turbulent conditions, penny stocks—though an old-fashioned term—remain an intriguing area for investors seeking value in smaller or newer companies. By focusing on those with strong financial foundations, such stocks can offer potential stability and growth opportunities. In this article, we explore three penny stocks that exhibit financial...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8031000-choice1-main-header/1585186592389","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8031000-choice1-main-header/1585186592389"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-ata/atturra-shares/news/asx-penny-stock-highlights-featuring-atturra-and-two-others","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-ata/atturra-shares/news/asx-penny-stock-highlights-featuring-atturra-and-two-others","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","BK7061","SRG.AU","VRS.AU","LU2517655291.USD","BK4588","XJO.AU","MXI.AU","BK7503","BK7016","FWD.AU","LU2362541273.HKD","BK7012","LU0154245673.USD","DSK.AU","XKO.AU","SSM.AU","LU2517655028.SGD","BK7077","BK7050","BK7506","BK4134","BK7055","BK7143","LU2362540622.SGD","IGL.AU","MTO.AU","XAO.AU","BK7067","BK7045","BK4585","ATA.AU","LU2517655374.HKD","LU0154245756.USD","LU1814569148.SGD","COV.AU","LU0107464264.USD","WAF.AU","GWA.AU","BK7128","LU2362541513.USD","PPS.AU","BK7014","IT"],"gpt_icon":0},{"id":"2584896438","title":"Cleo Diagnostics Ltd-Cleo Appoints First Key Opinion Leader to Support US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2584896438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584896438?lang=en_us&edition=fundamental","pubTime":"2025-11-19 07:03","pubTimestamp":1763506981,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUE8WS2TV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","COV.AU"],"gpt_icon":0},{"id":"2577537131","title":"3 Promising ASX Penny Stocks With Market Caps Below A$3B","url":"https://stock-news.laohu8.com/highlight/detail?id=2577537131","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577537131?lang=en_us&edition=fundamental","pubTime":"2025-10-24 03:02","pubTimestamp":1761246140,"startTime":"0","endTime":"0","summary":"The Australian market showed a mixed performance recently, with energy stocks leading the way due to geopolitical factors and materials remaining steady. In this context, penny stocks continue to attract attention for their potential to offer unique growth opportunities. Although the term \"penny stocks\" might seem outdated, these smaller or newer companies can still be promising investments when backed by strong financials and solid fundamentals.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pvt/pivotal-metals-shares/news/3-promising-asx-penny-stocks-with-market-caps-below-a3b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pvt/pivotal-metals-shares/news/3-promising-asx-penny-stocks-with-market-caps-below-a3b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7129","CLV.AU","DSK.AU","AAL.AU","BK7067","LBL.AU","PPL.AU","BK7036","BK7506","BK7104","BK7012","BK7143","BK7095","IGL.AU","BK7061","BK7128","BK7077","BK7045","BK7088","GWA.AU","WAF.AU","COV.AU","BK7014","FWD.AU","CIA.AU","MTO.AU","PVT.AU"],"gpt_icon":0},{"id":"2567840192","title":"Cleo Diagnostics Receives Positive US FDA Feedback for Ovarian Cancer Test; Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567840192","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567840192?lang=en_us&edition=fundamental","pubTime":"2025-09-15 10:50","pubTimestamp":1757904643,"startTime":"0","endTime":"0","summary":"Cleo Diagnostics  received positive feedback from the US Food and Drug Administration  at the second pre-submission meeting for its ovarian cancer pre-surgical triage test, according to a Monday filing with the Australian bourse.The feedback will help the company improve the robustness of its clinical trial design by strengthening data collection processes for a high-quality submission, the filing said.Shares rose 9% in midday trade Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COV.AU","BK7067"],"gpt_icon":0},{"id":"2566932274","title":"Companies Like Cleo Diagnostics (ASX:COV) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2566932274","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566932274?lang=en_us&edition=fundamental","pubTime":"2025-09-11 06:30","pubTimestamp":1757543421,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cov/cleo-diagnostics-shares/news/companies-like-cleo-diagnostics-asxcov-are-in-a-position-to","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cov/cleo-diagnostics-shares/news/companies-like-cleo-diagnostics-asxcov-are-in-a-position-to","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COV.AU","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}